KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Capital Employed (2020 - 2025)

Royalty Pharma's Return on Capital Employed history spans 6 years, with the latest figure at 0.08% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 1.0% year-over-year to 0.08%; the TTM value through Dec 2025 reached 0.08%, up 1.0%, while the annual FY2025 figure was 0.09%, 0.0% changed from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.08% at Royalty Pharma, down from 0.08% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.11% in Q1 2025 and bottomed at 0.02% in Q4 2022.
  • The 5-year median for Return on Capital Employed is 0.08% (2021), against an average of 0.07%.
  • The largest annual shift saw Return on Capital Employed decreased -7bps in 2021 before it rose 7bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.08% in 2021, then tumbled by -77bps to 0.02% in 2022, then surged by 390bps to 0.09% in 2023, then dropped by -18bps to 0.08% in 2024, then rose by 8bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for RPRX's Return on Capital Employed are 0.08% (Q4 2025), 0.08% (Q3 2025), and 0.11% (Q2 2025).